Noncardiac Comorbidities in Heart Failure With Preserved Ejection Fraction – A Commonly Ignored Fact –

  • Liu Ming
    Division of Cardiology, Department of Medicine and Therapeutics & Institute of Vascular Medicine & Institute of Innovative Medicine & Heart Education And Research Training (HEART) Center & Li Ka Shing Institute of Health Sciences & Prince of Wales Hospital, The Chinese University of Hong Kong
  • Fang Fang
    Division of Cardiology, Department of Medicine and Therapeutics & Institute of Vascular Medicine & Institute of Innovative Medicine & Heart Education And Research Training (HEART) Center & Li Ka Shing Institute of Health Sciences & Prince of Wales Hospital, The Chinese University of Hong Kong
  • Yu Cheuk-Man
    Division of Cardiology, Department of Medicine and Therapeutics & Institute of Vascular Medicine & Institute of Innovative Medicine & Heart Education And Research Training (HEART) Center & Li Ka Shing Institute of Health Sciences & Prince of Wales Hospital, The Chinese University of Hong Kong

この論文をさがす

抄録

It has been well described that many patients with heart failure (HF) have a normal left ventricular ejection fraction. This entity has been termed “heart failure with preserved ejection fraction (HFPEF)”. Significant advances have been made in understanding the clinical characteristics of HFPEF over the past 2 decades on the basis of large HF registries and randomized clinical trials. However, most multicenter clinical trials that investigated medical therapies in HFPEF have yielded disappointing results. HFPEF being a clinical syndrome involving multiple organ systems may be a potential explanation for treatment failure. In this review we discuss the prevalence of noncardiac comorbidities in HFPEF patients as well as their effect on the prognosis of HFPEF. (Circ J 2015; 79: 954–959)

収録刊行物

  • Circulation Journal

    Circulation Journal 79 (5), 954-959, 2015

    一般社団法人 日本循環器学会

被引用文献 (6)*注記

もっと見る

参考文献 (62)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ